Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - ACHILLION PHARMACEUTICALS INC | d262647d10k.htm |
| EX-3.1 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT - ACHILLION PHARMACEUTICALS INC | d262647dex31.htm |
| EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - ACHILLION PHARMACEUTICALS INC | d262647dex311.htm |
| EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - ACHILLION PHARMACEUTICALS INC | d262647dex322.htm |
| EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - ACHILLION PHARMACEUTICALS INC | d262647dex231.htm |
| EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ACHILLION PHARMACEUTICALS INC | d262647dex312.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ACHILLION PHARMACEUTICALS INC | Financial_Report.xls |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report on Form 10-K of Achillion Pharmaceuticals, Inc. (the “Company”) for the period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Michael D. Kishbauch, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350 as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: March 8, 2012 |
| /s/ MICHAEL D. KISHBAUCH |
| Michael D. Kishbauch |
| President and Chief Executive Officer |
A signed original of this written statement required by Section 906 has been provided to Achillion Pharmaceuticals, Inc. and will be retained by Achillion Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.